CervoMed Inc.
- CRVO
- NASDAQ
- Biotechnology
- Neurological Disorders
- Oral Small Molecule
- Age-Related Neurology
$2.23
Today −0.45%Quote Oct 19, 2026, 02:04 PM UTC
−12.16%over the last month
Max drawdown −32.9%From 1-month high −32.9%3 months −19.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$33.7M
Quote Oct 19
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$7.00
+213.9% from here
Floor
$2.17
2.7% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CRVOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
15
Founded
2010